Psilocybin might no be the most active ingredient in magic mushrooms, new research suggests
Study Paper – DMT is neither formed nor retained in serotonin terminals in the rat brain
Study Paper – A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial
Study Paper – Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults
A dose of psilocybin, a dash of rabies point to treatment for depression – Cornell Chronicle
Study Paper –Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks
Natural History Museum of Utah
Study Paper – Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression
Depression remission endures 5 years after psilocybin trial – Ohio State News
Study paper: Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder
Study Paper: Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms
Australia-first trial shows promising results for psychedelic-assisted therapy in palliative care
Compassionate Use Program for psilocybin possible for the first time in Germany
Podcast
Links
Support
BIPRP
Science Talk
Amanda's Talks
One-pager
Music
Amanda Feilding
Events
Highlights
Psilocybin for Depression
Current
Category
Substance/Method
Collaboration
Clinical Application
Policy Focus
Type of publication
Search type